Supplementary Table 2. Up-regulated genes in H6c7eR-Kr cells with signal log ratio >=2

Table 3. Genes reported previously as overexpressed in pancreatic cancer and are also identified in this study as putative downstream targets of K-ras oncogene activation in pancreatic duct cells

Supplementary Table 3. Down-regulated genes in H6c7eR-Kr cells with signal log ratio <= -2

Table S1. 143 significantly differentially expressed genes between Egr1-null and wild-type Primary Mouse Embryo Fibroblasts.

Table 1. Sixty-six significantly differentially expressed genes between Egr1-null and WT MEFs and related by the Egr1-regulatory pathway

Table 1. Microarray analysis of BT-20 cells transfected with FoxM1 siRNA

Table 1. Gene list of detectable and well-characterized death receptors and domains

Table 1. Whole-Genome Gene Expression Study Using Affymetrix GeneChips HG-U133A and HG-U133B

Supplementary table S2A: N/T+ set Genes selected by ANOVA test  at p<0.01 performed for each of the 1859 filtered genes comparing FTC positive for PAX8-PPAR? translocation with normal tissues. The 116 differentially expressed genes corresponding to the ?N/T+ set? are reported in this table.

Supplementary table S2B: N/T- set Genes selected by ANOVA test  at p<0.01 performed for each of the 1859 filtered genes comparing PAX8 FTC negative for PAX8-PPAR? translocation with normal tissue. The 61 differentially expressed genes corresponding to the ?N/T- set? are reported in this table.

Supplementary table 1C: T-/T+- set Genes selected by ANOVA test  at p<0.01 performed for each of the 1859 filtered genes comparing FTC positive and negative for PAX8-PPAR? translocation.. The 106 differentially expressed corresponding to ?T-/T+ set? are reported in this table.

Table 2. Genes Regulated by Progestin at 6 h

Table 3. Differential Regulation at 48 h

Table3b. Gene expression changes in T98G glioma cells (MGMT+) treated with BCNU during 48h

Table2a. Gene expression changes in A172 glioma cells (MGMT-deficient) treated with BCNU during 24h